| 英文别名： |
Dutasteride;(5alpha,17beta)-n-{2,5-bis(trifluoromethyl)phenyl}-3-oxo-4-azaandrost-l-ene-17-carboxamide;(4aR,6aS,7S,9aS,9bS,11aR)-N-[2,5-bis(trifluoromethyl)phenyl]-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide;(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-[2,5-bis(trifluoromethyl)phenyl]-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide;(4aR,6aS,7S)-N-[2,5-bis(trifluoromethyl)phenyl]-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide;Avodart;Duagen;GG 745;GI198745;Avolve;(5α,17β)-;Dutasteride API;GG-745, GI-198745,;Dutasteride (200 mg);Dutasteride(Avodart);GI 198745;O0J6XJN02I;Dutasteride, 99%;Avidart;Avidart;(4ar,4bs,6as,7s,9as,9bs,11ar)-n-[2,5-bis(trifluoromethyl)phenyl]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-1h-indeno[5,4-f]quinoline-7-carboxamide;(4ar,4bs,6as,7s,9as,9bs,11ar)-n-[2,5-bis(trifluoromethyl)phenyl]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-1h-indeno[5,4-f]quinoline-7-carboxamide;JALYN COMPONENT DUTASTERIDE;JALYN COMPONENT DUTASTERIDE;BCP02344;BCP02344;EX-A1952;EX-A1952;alpha,alpha,alpha,alpha',alpha',alpha'-Hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide;alpha,alpha,alpha,alpha',alpha',alpha'-Hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide;DUTASTERIDE [WHO-DD];DUTASTERIDE [WHO-DD];DUTASTERIDE (USP-RS);DUTASTERIDE (USP-RS);Dutasteride (JAN/USP/INN);Dutasteride (JAN/USP/INN);(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide;(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide;1H-Indeno(5,4-f)quinoline-7-carboxamide, N-(2,5-bis(trifluoromethyl)phenyl)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-;1H-Indeno(5,4-f)quinoline-7-carboxamide, N-(2,5-bis(trifluoromethyl)phenyl)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-;NCGC00164571-01;NCGC00164571-01;UNII-O0J6XJN02I;UNII-O0J6XJN02I;BD164398;BD164398;Dutasteride for system suitability, European Pharmacopoeia (EP) Reference Standard;GS-3565;Dutasteride for system suitability, European Pharmacopoeia (EP) Reference Standard;GS-3565;Dutasteride, >=98% (HPLC);Dutasteride, >=98% (HPLC);Z1558504346;DUTASTERIDE (MART.);Z1558504346;CHEMBL1200969;DUTASTERIDE (MART.);164656-23-9;CHEMBL1200969;DUTASTERIDE [MART.];164656-23-9;BCPP000248;DUTASTERIDE [MART.];(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-[2,5-bis(trifluoromethyl)phenyl]-4a,6a-dimethyl-2-oxo-1H,2H,4aH,4bH,5H,6H,6aH,7H,8H,9H,9aH,9bH,10H,11H,11aH-indeno[5,4-f]quinoline-7-carboxamide;BCPP000248;DTXSID8046452;CS-1542;(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-[2,5... |
沪公网安备31011402010658号 
